“May all be happy, may all be healed, may all be at peace and may no one ever suffer."
Malignant pleural mesothelioma is a rare but aggressive cancer that affects the pleura, the thin layer of tissue that lines the lungs and chest cavity. It is caused by exposure to asbestos, a naturally occurring mineral that was commonly used in construction and other industries before its health hazards became known.
Symptoms of malignant pleural mesothelioma can include chest pain, shortness of breath, fatigue, weight loss, and coughing up blood. Diagnosis usually involves imaging tests such as CT scans and MRI, as well as a biopsy of the affected tissue.
Treatment options for malignant pleural mesothelioma depend on the stage of the disease and the patient's overall health. Surgery, chemotherapy, and radiation therapy may all be used to try to control the cancer and relieve symptoms. However, because malignant pleural mesothelioma is often diagnosed in its later stages, the prognosis is generally poor, with a median survival of 12-18 months.
Prevention of malignant pleural mesothelioma involves minimizing exposure to asbestos. This may include taking precautions such as wearing protective clothing and masks in industries where asbestos exposure is a risk, and seeking professional help for the safe removal of asbestos from homes and other buildings.
In conclusion, malignant pleural mesothelioma is a serious and often fatal cancer that is caused by exposure to asbestos. Early detection and treatment are important for improving outcomes, and prevention of exposure to asbestos is key in reducing the incidence of this disease.